Advances in topical therapy for skin diseases

Medical Journal of Australia

Volumn 165, Issue 5, 1996, Pages 274-279

  Willsteed, Elizabeth M ^a,b,c  

^a New South Wales Government   (Australia)

^b SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; CALCIPOTRIOL; DOXEPIN; DRUG CARRIER; METHYLPREDNISOLONE; MOMETASONE FUROATE; STEROID; TERBINAFINE; TRICYCLIC ANTIDEPRESSANT AGENT;

DRUG CHOICE; HUMAN; MYCOSIS; ONYCHOMYCOSIS; PRURITUS; PSORIASIS; REVIEW; SIDE EFFECT; SKIN ABSORPTION; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

EID: 0029798638     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb124966.x     Document Type: Review

References (25)

1. Schalla W, Schaefer H. Pharmacokinetics and topical applications of drugs. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. Dermatology in general medicine. New York: McGraw Hill, 1987: 2525-2532.
2. 14C-cortisol in man. J Invest Dermatol 1967; 48: 181-183.
3. Wester RC, Noonan PK, Maibach HI. Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 1977; 113: 620-622.
4. Zaug M, Bergstraesser M, Amorolfine in the treatment of onychomycosis and dermatomycoses (an overview). Clin Exp Dermatol 1992; 71: 61-70.
5. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911-933.
6. Evans EGV Shah JM, Joshipura RC One week treatment of tinea corporis and tinea cruris with terbinafine 1% cream: a placebo-controlled study. J Dermatol Treat 1992; 3: 181-184.
7. Berman B. Ellis C, Leyden J, et al. Efficacy of a 1 week, twice daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 1992; 26: 956-960.
8. Hill S, Thomas R, Smith SG, et al. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream. Br J Dermatol 1992; 127: 396-400.
9. Greaves MW. Itching - research has barely scratched the surface. N Engl J Med 1992; 326: 1016-1017.
10. 1 receptors. Mayo Clin Proc 1979, 54: 669-674.
11. Bernstein JE, Whitney DH, Soltani K. Inhibition of histamine induced pruritus by topical tricyclic antidepressants. J Am Acad Dermatol 1981; 5: 582-585.
12. Drake LA, Millikan LE. Doxepin Study Group. The antipruritic effect of 5% Doxepin cream in patients with eczematous dermatitis. Arch Dermatol 1995; 131: 1403-1408.
13. Taylor JS, Praditsuwan P, Handel D, et al. Allergic contact dermatitis from Doxepin Cream. Arch Dermatol 1996; 132: 515-518.
14. Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24: 603-607.
15. Medansky RS, Bressinck R, Cole GW, et al. Mometasone furoate ointment and cream 0.1% in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025% and triamcinolone acetonide 0.1%. Cutis 1988; 42: 480-485.
16. Kecskes A, Hegar-Mahn D, Kleine Kuhlmann R, Lange L. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal anti-inflammatory activity. J Am Acad Dermatol 1993; 29: 576-580.
17. AAD Guidelines Committee, Guidelines of care: use of topical steroids. American Academy of Dermatology, 1995: 21-24.
18. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions J Invest Dermatol 1986; 7: 709-714.
19. Bruce S, Epinette WW, Funicella T, et al. Comparative study of calcipotriene (MC903) ointment and fluocinonide ointment in the treatment of psoriasis. J Am Acad Dermatol 1994; 31: 755-759.
20. Lebwohl MG. The evolution of Vitamin D analogues for the treatment of psoriasis [editorial). Arch Dermatol 1995; 131: 1323-1325.
21. Tham SN, Lun KG, Cheong WK, A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994; 131: 673-677.
22. Levy J, Gassmiller J, Schroder G, et al. Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 1994; 7: 231-236.
23. Ramsay CA, Berth-Jones J, Grunden G, et al. Longterm use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-264.
24. Hardman KA, Heath DA, Nelson HM. Hypercalcemia associated with calcipotriol (Dovonex) treatment. BMJ 1993; 306: 896.
25. Berth-Jones J, Bourke JF, Iqbal SJ, Hutchinson PE. Urine calcium excretion during treatment of psoriasis with topical calcipotriol. Br J Dermatol 1993; 129: 411-414.